Skip to content
10-Q

Quarterly Report

Galera Therapeutics, Inc. GRTX

0001563577-26-000014

← back to feed
Filed
May 14, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · May 12, 2026 160.43M sh
Shares Diluted Q1 2026 · Mar 31, 2026 98.5M sh
Shares Diluted Q1 2026 · Mar 31, 2025 98.5M sh
Operating Cash Flow Q1 2026 · Mar 31, 2026 −$875K
Operating Cash Flow Q1 2026 · Mar 31, 2025 −$2.24M
Cash And Equivalents Q1 2026 · Mar 31, 2026 $5.5M
Cash And Equivalents Q1 2026 · Dec 31, 2025 $6.38M
Stockholders Equity Q1 2026 · Mar 31, 2026 $728K
Stockholders Equity Q1 2026 · Dec 31, 2025 $3.97M
Stockholders Equity Q1 2026 · Mar 31, 2025 −$147.23M
Stockholders Equity Q1 2026 · Dec 31, 2024 −$148.04M
Total Liabilities Q1 2026 · Mar 31, 2026 $1.14M
Total Liabilities Q1 2026 · Dec 31, 2025 $645K
Current Assets Q1 2026 · Mar 31, 2026 $6.06M
Current Assets Q1 2026 · Dec 31, 2025 $7.1M
Total Assets Q1 2026 · Mar 31, 2026 $6.16M
Total Assets Q1 2026 · Dec 31, 2025 $7.2M
Eps Diluted Q1 2026 · Mar 31, 2026 −$0.01
Eps Diluted Q1 2026 · Mar 31, 2025 −$0.01
Eps Basic Q1 2026 · Mar 31, 2026 −$0.01
Eps Basic Q1 2026 · Mar 31, 2025 −$0.01
Sga Expense Q1 2026 · Mar 31, 2026 $1.64M
Sga Expense Q1 2026 · Mar 31, 2025 $1.87M
Rd Expense Q1 2026 · Mar 31, 2026 $15K
Rd Expense Q1 2026 · Mar 31, 2025 $93K
Net Income Q1 2026 · Mar 31, 2026 −$1.61M
Net Income Q1 2026 · Mar 31, 2025 −$1.59M
Operating Income Q1 2026 · Mar 31, 2026 −$1.66M
Operating Income Q1 2026 · Mar 31, 2025 −$1.96M
Stock Issued Q1 2026 · Dec 31, 2024 21.07M sh